SPC Financial Inc. Raises Stock Holdings in The Clorox Company $CLX

SPC Financial Inc. boosted its stake in The Clorox Company (NYSE:CLX) by 18.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,745 shares of the company’s stock after buying an additional 735 shares during the period. SPC Financial Inc.’s holdings in Clorox were worth $570,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of CLX. Sumitomo Mitsui DS Asset Management Company Ltd boosted its holdings in Clorox by 0.6% in the first quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,266 shares of the company’s stock valued at $1,953,000 after purchasing an additional 73 shares in the last quarter. Horizon Investments LLC boosted its holdings in Clorox by 4.4% in the first quarter. Horizon Investments LLC now owns 1,768 shares of the company’s stock valued at $258,000 after purchasing an additional 75 shares in the last quarter. Sfmg LLC boosted its holdings in Clorox by 2.8% in the first quarter. Sfmg LLC now owns 2,780 shares of the company’s stock valued at $409,000 after purchasing an additional 76 shares in the last quarter. Hancock Whitney Corp boosted its holdings in Clorox by 4.3% in the first quarter. Hancock Whitney Corp now owns 2,064 shares of the company’s stock valued at $304,000 after purchasing an additional 86 shares in the last quarter. Finally, American National Bank & Trust boosted its holdings in Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after purchasing an additional 89 shares in the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the sale, the chief operating officer owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.57% of the stock is owned by company insiders.

Clorox Price Performance

Clorox stock opened at $120.14 on Monday. The Clorox Company has a 12 month low of $116.53 and a 12 month high of $171.37. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The business has a 50 day simple moving average of $122.21 and a 200-day simple moving average of $128.57. The stock has a market capitalization of $14.63 billion, a PE ratio of 18.43, a price-to-earnings-growth ratio of 0.98 and a beta of 0.52.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.94 billion. During the same quarter in the prior year, the business earned $1.82 earnings per share. The company’s quarterly revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be paid a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a dividend yield of 4.1%. The ex-dividend date is Wednesday, October 22nd. Clorox’s dividend payout ratio is 76.07%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. Wells Fargo & Company lowered their price target on Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a report on Thursday, September 25th. UBS Group lowered their price target on Clorox from $134.00 to $128.00 and set a “neutral” rating for the company in a report on Wednesday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Clorox in a report on Saturday, September 27th. Barclays lowered their price target on Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a report on Tuesday, September 30th. Finally, The Goldman Sachs Group reduced their price objective on Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research note on Wednesday, October 1st. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Reduce” and a consensus price target of $131.92.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.